Bittium Biosignals and Preventice Technologies extend supply agreement for ECG monitors

Bittium Biosignals Ltd, a subsidiary of Bittium Corporation, signed an extension to its supply agreement with Preventice Technologies, Inc. to supply BodyGuardian MINI cardiac arrhythmia monitors. The total value is approximately USD 22.9 million, with revenues recognized from 2021 to 2024.

“If materialized in full, the total value of the agreement signed today is approximately USD 22.9 million.”news.cision.com

• 1 source
• news.cision.comBittium Biosignals Ltd, a Subsidiary of Bittium Corporation, and Preventice Technologies, Inc. Have Signed an Extension to Their Supply Agreement of ECG Monitoring Devices - Bittium OyjSep 10, 2020

Summarized from public sources; check the original articles before acting on it.